Diabetic retinopathy (DR) affects over 93 million people worldwide and is the number one
cause of blindness among working age adults. These indicators coupled with the projected …

Lipid metabolic abnormalities have emerged as potential risk factors for the development
and progression of diabetic complications, including diabetic retinopathy (DR). This review …

Introduction: Diabetic retinopathy (DR) is a significant cause of visual impairment worldwide.
The association between hyperlipidemia or dyslipidemia and DR has been investigated …

Diabetic retinopathy is the most disabling complication of diabetes, affecting 65% of patients
after 10 years of the disease. Current treatment options for diabetic retinopathy are highly …

Diabetic retinopathy (DR) is one of the major microvascular complications of diabetes. In
developed countries, it is the most common cause of preventable blindness in diabetic …

Diabetic retinopathy (DR) is a significant cause of vision loss and a research subject that is
constantly being explored for new mechanisms of damage and potential therapeutic options …

Diabetic RETINOPATHY is a chronic complication of DIABETES that can result in blindness.
Generally, there are two stages of diabetic RETINOPATHY, non-proliferative and …

AIM To clarify this controversy and to provide evidence for application of lipid lowering
agents in treatment of diabetic retinopathy (DR). METHODS We searched the databases of …

Hyperlipidemia is correlated with a series of health problems. Notably, aside from its
established role in promoting cardiovascular morbidity and mortality, hyperlipidemia has …

Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus (DM)
and is considered as the leading cause of visual impairment in working-aged adults …